Yasuhide Ikenaka

Nara Medical University — Japan

Medicine · Health Sciences

29h-index3.4kcitations62works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Liver Disease Diagnosis and Treatment(15), Cancer, Hypoxia, and Metabolism(15), Angiogenesis and VEGF in Cancer(13), Hormonal Regulation and Hypertension(13), Liver physiology and pathology(12)

Publications62 total

Dipeptidyl peptidase-4 inhibitor attenuates hepatic fibrosis via suppression of activated hepatic stellate cell in rats
Journal of Gastroenterology·2013· 130 cited
Dual blockade of angiotensin‐<scp>II</scp> and aldosterone suppresses the progression of a non‐diabetic rat model of steatohepatitis
Hepatology Research·2012· 21 cited
Possible Involvement of Angiogenesis in Chronic Liver Diseases: Interaction Among Renin-Angiotensin-Aldosterone System, Insulin Resistance and Oxidative Stress
Current Medicinal Chemistry·2012· 24 cited
Impact of Renin-Angiotensin System in Hepatocellular Carcinoma
Current Cancer Drug Targets·2011· 25 cited
Salvage living donor liver transplantation after percutaneous transluminal angioplasty for recurrent Budd-Chiari syndrome: a case report
Journal of Medical Case Reports·2011· 2 citedOpen Access
Combination treatment of angiotensin II type I receptor blocker and new oral iron chelator attenuates progression of nonalcoholic steatohepatitis in rats
American Journal of Physiology-Gastrointestinal and Liver Physiology·2011· 55 cited
Soluble VEGF receptor-2 may be a predictive marker of anti-angiogenic therapy with clinically available safe agents
Oncology Letters·2010· 8 citedOpen Access
PSEUDOMEMBRANOUS COLITIS COMPLICATING ULCERATIVE COLITIS
Digestive Endoscopy·2010· 6 citedOpen Access
Selective aldosterone blocker, eplerenone, attenuates hepatocellular carcinoma growth and angiogenesis in mice
Hepatology Research·2010· 21 cited
Abstract 2470: Clinically used selective aldosterone blocker attenuates hepatocarcinogenesis via angiogenesis inhibition in rats
Cancer Research·2010
Abstract 2469: Combination of branched-amino acids and ACE inhibitor attenuates the insulin resistance-based hepatocarcinogenesis via angiogenesis suppression
Cancer Research·2010
Abstract 3439: An alternative VEGF-targeted therapy and possible prediction against hepatocellular carcinoma (HCC) using combination of clinically available agents
Cancer Research·2010· 1 cited
Abstract 2468: Selective aldosterone blocker inhibits murine hepatocellular carcinoma development via angiogenesis suppression
Cancer Research·2010
The vascular endothelial growth factor (VEGF) receptor-2 is a major regulator of VEGF-mediated salvage effect in murine acute hepatic failure
Journal of Angiogenesis Research·2010· 7 citedOpen Access
Attenuation of insulin-resistance-based hepatocarcinogenesis and angiogenesis by combined treatment with branched-chain amino acids and angiotensin-converting enzyme inhibitor in obese diabetic rats
Journal of Gastroenterology·2009· 30 cited
Combination of vitamin K2 and angiotensin-converting enzyme inhibitor ameliorates cumulative recurrence of hepatocellular carcinoma
Journal of Hepatology·2009· 88 cited
Branched-chain amino acids suppress insulin-resistance-based hepatocarcinogenesis in obese diabetic rats
Journal of Gastroenterology·2009· 64 cited
Development of hepatocellular carcinoma in a patient 13 years after sustained virological response to interferon against chronic hepatitis C: a case report
Cases Journal·2009· 20 citedOpen Access
Crosstalk between angiogenesis, cytokeratin-18, and insulinresistance in the progression of non-alcoholic steatohepatitis
World Journal of Gastroenterology·2009· 41 citedOpen Access
Losartan, an angiotensin-II type 1 receptor blocker, attenuates the liver fibrosis development of non-alcoholic steatohepatitis in the rat
BMC Research Notes·2009· 57 citedOpen Access
page 1 of 4Next →

Frequent Co-authors

Hitoshi Yoshiji(49), Ryuichi Noguchi(46), Hiroshi Fukui(43), Junichi Yoshii(38), Koji Yanase(32), Mitsuteru Kitade(31), Tadashi Namisaki(30), Shigeki Kuriyama(26), Masaharu Yamazaki(23), Kosuke Kaji(20), Hirohisa Tsujinoue(18), Tatsuhiro Tsujimoto(15), Masahito Uemura(14), Hideto Kawaratani(12), Yusaku Shirai(10), Yosuke Aihara(9), Hiroo Imazu(8), Takemi Akahane(8), Toshiya Nakatani(7), Tsutomu Masaki(6)